Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
1. The primary objective of this study is:
- To evaluate the magnitude of the protective effect of the combination of budesonide
and formoterol on an as-needed basis compared to the use of terbutaline as-needed
on exercise induced bronchoconstriction in adults and adolescents with mild
intermittent asthma
2. The secondary objectives of this study are:
- To evaluate the magnitude of the protective effect of the combination of budesonide
and formoterol as-needed compared to regular once daily use of budesonide plus
terbutaline as-needed on exercise induced bronchoconstriction in adults and
adolescents with mild intermittent asthma
- To evaluate safety of budesonide/formoterol as-needed, terbutaline as-needed and
regular use of budesonide + terbutaline as-needed as terms of adverse event
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate Terbutaline